Pharmaceutical Residues in the Environment

Pharmaceuticals, due to their pseudo-persistence and biological activity as well as their extensive use in human and veterinary medicine, are a class of environmental contaminants that is of emerging concern. In contrast to some conventional pollutants, they are continuously delivered at low levels,...

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2020
Language:English
Physical Description:1 electronic resource (292 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 04823nam-a2201129z--4500
001 993545961404498
005 20231214133657.0
006 m o d
007 cr|mn|---annan
008 202105s2020 xx |||||o ||| 0|eng d
035 |a (CKB)5400000000040915 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/69294 
035 |a (EXLCZ)995400000000040915 
041 0 |a eng 
100 1 |a Kumirska, Jolanta  |4 edt 
245 1 0 |a Pharmaceutical Residues in the Environment 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2020 
300 |a 1 electronic resource (292 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a Pharmaceuticals, due to their pseudo-persistence and biological activity as well as their extensive use in human and veterinary medicine, are a class of environmental contaminants that is of emerging concern. In contrast to some conventional pollutants, they are continuously delivered at low levels, which might give rise to toxicity even without high persistence rates. These chemicals are designed to have a specific physiological mode of action and to resist frequently inactivation before exerting their intended therapeutic effect. These features, among others, result in the bioaccumulation of pharmaceuticals which are responsible for toxic effects in aquatic and terrestrial ecosystems. It is extremely important to know how to remove them from the environment and/or how to implement procedures or treatments resulting in their biological inactivation. Although great advances have been made in their detection in aquatic matrices, there remains limited analytical methodologies available for the trace analysis of target and non-target pharmaceuticals in matrices such as soils, sediments, or biota. There are still many gaps in the data on their fate and behavior in the environment as well as on their threats to ecological and human health. This book has included nine current research and three review articles in this field. 
546 |a English 
650 7 |a Research & information: general  |2 bicssc 
650 7 |a Environmental economics  |2 bicssc 
653 |a ifosfamide 
653 |a cyclophosphamide 
653 |a 5-fluorouracil 
653 |a cytostatic drug 
653 |a BDD anode 
653 |a electrochemical oxidation 
653 |a intermediates 
653 |a lincomycin 
653 |a monensin 
653 |a roxarsone 
653 |a migration 
653 |a residual 
653 |a toxicity 
653 |a pharmaceuticals 
653 |a endocrine disrupting compounds 
653 |a hydroponic cultivation 
653 |a determining target pollutants in plant materials 
653 |a municipal wastewater treatment plants 
653 |a ionic liquids 
653 |a green chemistry 
653 |a environmental and biological samples 
653 |a sample preparation 
653 |a determination of pharmaceuticals 
653 |a chromatographic methods 
653 |a electromigration techniques 
653 |a sulfamethoxazole 
653 |a antibiotic resistance genes 
653 |a sul genes 
653 |a bacterial community 
653 |a constructed wetlands 
653 |a environmental contaminants 
653 |a pharmaceuticals occurrence 
653 |a aquatic compartments 
653 |a soil 
653 |a poultry farms 
653 |a ultra-high performance liquid chromatography 
653 |a antibiotics, antibiotic resistance 
653 |a antibiotics 
653 |a wastewater 
653 |a sewage sludge 
653 |a risk assessment 
653 |a removal efficiency 
653 |a LC-MS/MS analysis 
653 |a Spirotox 
653 |a fluoxetine 
653 |a sertraline 
653 |a paroxetine 
653 |a mianserin 
653 |a pharmaceuticals in the environment 
653 |a wastewaters 
653 |a pharmaceutical residues 
653 |a conventional wastewater treatments 
653 |a solid phase extraction 
653 |a pharmaceuticals toxicity 
653 |a environmental risk assessment 
653 |a antibiotic resistance genes (ARGs) 
653 |a antibiotic-resistant bacteria (ARB) 
653 |a wastewater treatment plants (WWTPs) 
653 |a activated sludge (AS) 
653 |a constructed wetlands (CWs) 
653 |a environmental pollution 
653 |a spread of resistance 
653 |a tetracyclines 
653 |a sulfonamides 
653 |a fate in the environment 
653 |a fate in WWTPs 
653 |a ecotoxicity 
653 |a antibiotic resistance 
653 |a development of methods 
776 |z 3-03943-485-3 
776 |z 3-03943-486-1 
700 1 |a Kumirska, Jolanta  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 06:02:21 Europe/Vienna  |f system  |c marc21  |a 2022-04-04 09:22:53 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338080980004498&Force_direct=true  |Z 5338080980004498  |b Available  |8 5338080980004498